I Looked at 5 GLP-1 Programs You Can Actually Pay For Out of Pocket

The assumption that you need insurance to afford a GLP-1 is wrong. It is also, increasingly, the opposite of reality. Branded Wegovy can cost $1,300 or more per month without a coupon, yes, but the telehealth cash-pay market has quietly become the more accessible route for a lot of people, especially since compounded versions dropped prices well below what most insurance co-pays actually land at after the deductible fight. What follows is how I’d actually think through the options if I were starting from zero, no insurance, no employer subsidy, just a credit card and a browser.

1. HealthRX

Start here if price is the first filter you apply. Compounded semaglutide comes in at $99 per month, and compounded tirzepatide at $149. Those are among the lowest published cash prices I found for a program that still includes physician oversight and medication in one number.

A few specifics worth knowing. The pharmacy filling these orders is Manifest Pharmacy in Greer, South Carolina, a 503A-licensed compounding facility that operates under USP-797 standards with lot-tracking from bench to patient. That is a meaningful detail because a number of telehealth companies send prescriptions to compounding labs they never name publicly, which makes quality verification impossible. HealthRX also carries LegitScript certification (cert 50087439), and the physician review happens inside roughly 24 hours. Shipping is overnight and free to all 50 states, which matters if you live somewhere that a lot of smaller telehealth outfits simply skip.

The clinical context they reference is trial-based, not their own outcomes: semaglutide showed roughly 15% average body weight loss at 68 weeks in the STEP 1 trial, and tirzepatide showed approximately 21% at 72 weeks in SURMOUNT-1. Compounded versions are not FDA-approved and are not equivalent to the branded drugs, and any program you choose should make that distinction clearly. HealthRX does.

For someone who wants a low entry price, a named pharmacy, and no contract, this is where I’d start.

2. FormBlends

FormBlends is worth considering if your priorities shift slightly toward documented quality assurance or if you want GLP-1 treatment alongside other peptide therapies from the same clinical setup.

The pharmacy is an FDA-registered 503A compounder, and FormBlends publishes per-product purity testing: HPLC purity percentages, mass spec identity confirmation, and endotoxin and sterility results. Most GLP-1 telehealth brands do not publish this level of batch documentation. If you are the kind of person who wants to see the actual numbers before injecting anything, that transparency is genuinely rare in this category.

Pricing runs higher than HealthRX. Semaglutide is around $299 per vial and tirzepatide around $349. For some people that premium is worth paying for the published lab documentation. The other differentiator is catalog depth: FormBlends also carries recovery, longevity, and cognitive peptides under the same physician-supervised model, so if you already use or are curious about peptides beyond GLP-1s, you can manage everything in one place. Shipping reaches 47 states, not 50, so check your state first.

The honest summary: HealthRX wins on price and nationwide reach. FormBlends wins if purity documentation or a wider peptide catalog matters more to you than entry price.

3. Mochi Health

Mochi‘s pricing structure is unusually transparent for this space. Compounded semaglutide runs about $99 per month, and compounded tirzepatide around $199. What makes Mochi different from many cash-pay programs at similar price points is the clinical staffing: the prescribers are board-certified obesity medicine physicians, not general practitioners doing GLP-1 scripts on the side. That distinction actually changes the quality of the dosing conversation, particularly for patients with metabolic complications or a prior history of weight cycling.

Monitoring is more involved than at some of the lighter-touch platforms. That can feel like friction, but it tends to produce better outcomes over a 6-to-12-month arc. If you want cheap-and-minimal, Mochi might feel like too much oversight. If you want a clinical program that happens to also be affordable, it earns its spot.

4. Henry Meds

Henry Meds is squarely in the cash-pay compounded space, with pricing that typically lands between $179 and $249 for the first month. The shipping speed stands out: most orders go out within 24 to 72 hours, which is faster than several competitors. The monitoring is lighter than what you get at Mochi or a premium program like Form Health, so if you are already familiar with GLP-1 injection protocols and want less hand-holding, Henry is a reasonable fit.

One note: the FDA sent warning letters to more than 30 telehealth and compounding firms in early 2026, and the regulatory environment around compounded GLP-1s remains in motion. Any cash-pay compounded program carries that caveat. Henry, like HealthRX and the others here, is operating in a space that is legal and active but subject to ongoing federal oversight.

5. Ro Body

Ro takes a different approach to the insurance problem. The membership fee is low, around $39 for the first month and $74 to $149 per month after that, and the medication is billed separately. What Ro offers that most pure cash-pay platforms do not is a prior authorization team that actually tries to work the insurance angle on your behalf. If you have insurance that might cover a branded GLP-1 but you have avoided the paperwork nightmare, Ro is one of the few services that will push through that process for you.

For people without insurance, the medication cost is the main variable. Branded semaglutide and tirzepatide without coverage are expensive even through telehealth. Ro moved toward branded medications after the March 2026 Novo Nordisk settlement ended many platforms’ compounded semaglutide programs, so the cost picture there is different from the compounded options above. Worth checking their current pricing before assuming what you will pay.

HealthRX gets a mention here not as a ranked comparison to Ro but because the two serve genuinely different use cases. Ro is built for people who want to attempt the insurance route. HealthRX is built for people who have already decided to pay cash and want the lowest defensible price with named pharmacy documentation.

A Straightforward Caution

Compounded GLP-1 medications are not FDA-approved products. They are prepared by licensed compounding pharmacies under state and federal rules, but they have not gone through the same approval process as Ozempic, Wegovy, or Zepbound. The active ingredient is the same molecule, but potency, sterility, and formulation consistency depend entirely on the pharmacy’s practices. That is why the pharmacy name and its certifications matter, and why published testing data matters. Talk to a physician before starting any of these programs, including the telehealth ones that include a physician review as part of the process.

Common Questions

Is compounded semaglutide from HealthRX or Mochi the same drug as Wegovy?

No, and the distinction matters. The active molecule is semaglutide in both cases, but compounded versions are not FDA-approved and have not gone through the same manufacturing review as Wegovy. Quality depends on the specific compounding pharmacy. HealthRX names its pharmacy publicly; Mochi’s compounded supply has varied. Ask before you order.

What happens to my cash-pay program if the FDA tightens rules on compounded GLP-1s again?

It depends on the platform. Ro already shifted toward branded medications after the March 2026 regulatory changes. Programs built entirely around compounded semaglutide or tirzepatide, including HealthRX and Henry Meds, would need to either switch to branded drugs (at much higher prices) or pause offerings. Check each company’s policy on this before committing to a multi-month supply.

Why does FormBlends cost three times more than HealthRX if they both use compounded tirzepatide?

The price gap reflects published lab documentation. FormBlends releases HPLC purity percentages, mass spec identity confirmation, and sterility results per batch. HealthRX does not publish that level of testing data, though it does name its pharmacy and holds LegitScript certification. Whether that difference in transparency is worth roughly $200 more per month is a personal call.

Can Ro actually get insurance to cover a GLP-1 if my plan has denied it before?

Sometimes. Ro employs a prior authorization team that re-submits appeals and documents medical necessity, which is more than most platforms do. Success rates are not published, and prior denials are not automatically reversed. But if you have employer-paid insurance and have never formally applied, Ro’s process is more systematic than trying to work through it yourself.

If I want the lowest possible monthly cost right now, which program makes the most sense?

HealthRX and Mochi both list compounded semaglutide at $99 per month, which is the lowest price point across these five programs. HealthRX ships to all 50 states and includes overnight delivery; Mochi pairs that price with board-certified obesity medicine physicians, which adds clinical depth but also more monitoring requirements. The right answer depends on whether you want minimal friction or more clinical structure.

Sources

• STEP 1 trial: Wilding et al., *New England Journal of Medicine*, 2021 (semaglutide 2.4 mg, 68-week weight outcomes)
• SURMOUNT-1 trial: Jastreboff et al., *New England Journal of Medicine*, 2022 (tirzepatide, 72-week weight outcomes)
• FDA warning letters to telehealth/compounding firms, January-February 2026: FDA.gov public enforcement records
• Novo Nordisk settlement / compounded semaglutide market shift, March 9 2026: reported by Reuters, STAT News
• LegitScript public certification registry: LegitScript.com
• Ro, Mochi Health, Henry Meds, Hims & Hers pricing: publicly listed on each brand’s website as of mid-2026